Research

LIke ThisLIke ThisLIke This

Mark Daniel Fleming, MD, DPhil

Mark Fleming MD DPhil
Department:
Pathology Research
Hospital Title:
Pathologist-in-Chief
Academic Title:
S. Burt Wolbach Professor of Pathology, Harvard Medical School
Research Focus Area:
Molecular Genetics of Erythroid Iron Metabolism
Contact:
617-919-2664
Contact Via Email
Send an email to SendYour Name*Your Email Address*Subject*Comments*

Research Overview

Mark Fleming's research is focused on determining how erythroid cells acquire and utilize iron. Researchers in his lab are pursuing two general approaches: Postionally cloning and characterizing the genes underlying several mouse hereditary defects in erythroid iron metabolism. Using targeted mutagenesis in the mouse to study proteins implicated in the pathogenesis in a group of bone marrow disorders known as sideroblastic anemias. In those disorders, erythroid precursors develop pathologic iron deposits in mitochondria, which play a unique role in metabolizing iron and heme. He is seeking to characterize proteins responsible for mitochondrial iron import and utilization. 

About Mark Fleming

Mark Fleming earned his undergraduate degree in molecular biology from Princeton University in 1987, his doctor of philosophy degree in organic chemistry from the University of Oxford in England in 1990 and his medical degree from Harvard Medical School in 1993. Dr. Fleming did his residency in anatomic pathology and fellowship in hematopathology at Brigham and Women's Hospital. He also did a postdoctoral fellowship in the Division of Hematology/Oncology here at Children's. Dr. Fleming was named a Pew Fellow in Biomedical Research

LIke ThisLIke ThisLIke This
Close